NCT05556499View on ClinicalTrials.gov

The Bone-parathyroid Crosstalk in Primary Hyperparathyroidism

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2022

Primary Completion Date

May 24, 2026

Study Completion Date

June 24, 2026

Conditions
Hyperparathyroidism, PrimaryOsteoporosisParathyroid Neoplasms
Interventions
DIAGNOSTIC_TEST

Biomarker assays

Circulating bone biomarkers assays

Trial Locations (1)

20157

IRCCS Istituto Ortopedico Galeazzi, Milan

All Listed Sponsors
lead

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

OTHER

NCT05556499 - The Bone-parathyroid Crosstalk in Primary Hyperparathyroidism | Biotech Hunter | Biotech Hunter